SpectronRx
Website to be confirmed.
About SpectronRx
SpectronRx is a Radiopharma Developer company; the kind of vendor BD teams should have a 15-minute conversation with at SNMMI.
Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.
What we're seeing
- Endpoints News · 2026-08-17Spectronrx expands cyclotron capacity to meet Lu-177 demandThe announcement comes amid tightening Mo-99 and Lu-177 supply.
- Reuters Health · 2026-03-26Spectronrx partners with academic center on Actinium-225 programThe work builds on more than a decade of radiochemistry collaboration.
- BioPharma Reporter · 2026-02-03Spectronrx files IND for next-generation PSMA-targeted agentThe announcement comes amid tightening Mo-99 and Lu-177 supply.
Mocked while we wire the Exa integration. Headlines are illustrative.
What we expect to see at the booth
Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.
A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.
Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.
Companies you may also want to visit.
Actinium Pharmaceuticals
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Actinium Pharmaceuticals.
View profile →AtomVie Global Radiopharma Inc.
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on AtomVie Global Radiopharma Inc..
View profile →Bayer Oncology
Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Bayer Oncology.
View profile →